David Eberhard MD

David Eberhard, MD, PhD, is a pathologist, scientist, and executive specializing in oncology with extensive experience in translational and basic research, drug development, and biomarkers. They have held prominent positions as Chief Medical Pathologist at Flagship Biosciences, Chief Medical Officer at Inivata, and currently serve as a Consultant Pathologist at Natera and Chief Medical Officer at MultiplexDX International. Eberhard has also contributed to academia as an Associate Professor at the University of North Carolina at Chapel Hill, focusing on cancer genomics. Their expertise encompasses molecular and anatomic pathology, genomic oncology, and precision medicine strategies.